-
Mashup Score: 4Poster Session & Reception - 4 day(s) ago
Official website for the University of Miami Leonard M. Miller School of Medicine
Source: med.miami.eduCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 16Dietary pro-oxidant therapy by a vitamin K precursor targets PI 3-kinase VPS34 function - 2 month(s) ago
Men taking antioxidant vitamin E supplements have increased prostate cancer (PC) risk. However, whether pro-oxidants protect from PC remained unclear. In this work, we show that a pro-oxidant vitamin K precursor [menadione sodium bisulfite (MSB)] …
Source: www.science.orgCategories: General Medicine News, Hem/OncsTweet-
Supercool to hear a story from Lloyd Trottman @CSHL inspired by SELECT data from @EricKleinMD and just published in @ScienceMagazine! https://t.co/85w2F66P2i https://t.co/sWG4Ilc5oR
-
-
Mashup Score: 16Dietary pro-oxidant therapy by a vitamin K precursor targets PI 3-kinase VPS34 function - 3 month(s) ago
Men taking antioxidant vitamin E supplements have increased prostate cancer (PC) risk. However, whether pro-oxidants protect from PC remained unclear. In this work, we show that a pro-oxidant vitamin K precursor [menadione sodium bisulfite (MSB)] …
Source: www.science.orgCategories: General Medicine News, Hem/OncsTweet-
Supercool to hear a story from Lloyd Trottman @CSHL inspired by SELECT data from @EricKleinMD and just published in @ScienceMagazine! https://t.co/85w2F66P2i https://t.co/sWG4Ilc5oR
-
-
Mashup Score: 1Andrew V. Schally, 97, Dies; Scientist Shared Nobel Glory With Rival - 3 month(s) ago
His two-decade quest to find elusive brain hormones became a race against Roger Guillemin, a onetime colleague and an eventual fellow prizewinner.
Source: www.nytimes.comCategories: General Medicine News, Hem/OncsTweet-
Andrew V. Schally, 97, Dies; Scientist Shared Nobel Glory With Rival - The New York Times https://t.co/xGwBvNAtYy
-
-
Mashup Score: 21Enzalutamide in metastatic hormone-sensitive prostate cancer: A plain language summary of the ARCHES and ENZAMET follow-up studies - 4 month(s) ago
This summary includes information from the ARCHES and ENZAMET follow-up studies. Both studies looked at enzalutamide treatment for people with metastatic hormone-sensitive prostate cancer (known as…
Source: www.tandfonline.comCategories: General Medicine News, Hem/OncsTweet-
So much of what we write is complex and nuanced. Thank you @AarmstrongDuke @Prof_IanD@AzadOncology for writing A plain language summary of the ARCHES and ENZAMET follow-up studies @PCFnews @AmericanCancer https://t.co/Cd4dZ0Hvld
-
-
Mashup Score: 11Refugee Assistance Alliance - 4 month(s) ago
WELCOMING AND SUPPORTING REFUGEES IN SOUTH FLORIDA Donate
Categories: General Medicine News, Hem/OncsTweet-
Enjoyed spending the evening with Refugee Assistance Alliance, which does incredible work for support and resettlement in South Florida. Heard many stories for folks who simply need the basics to live. Wonderful to see community support. https://t.co/12iHrPCY3s https://t.co/Fw4P6DuC2E
-
-
Mashup Score: 6Innovation in Action: Revolutionizing Healthcare | Small Molecule Therapeutics for Castration Resistant Prostate Cancer - 4 month(s) ago
Shaun Stauffer, PhD, and Nima Sharifi, MD, discuss the roles of several proteins in castration resistant prostate cancer and their identification as novel targets for new therapeutics. The webinar session covers the development of these new drug candidates and how they might be applied to improve patient care.
Source: newsroom.clevelandclinic.orgCategories: General Medicine News, Hem/OncsTweet-
https://t.co/DXa9xpuMwT @SStaufferPhD @dsui_miami_uro @ClevelandClinic
-
-
Mashup Score: 22Do genetics increase prostate cancer risk? - 4 month(s) ago
Prostate cancer is the 2nd most common cause of cancer death in U.S. men. While initial treatments offer hope, many patients find that their cancer returns with
Source: podcasts.apple.comCategories: General Medicine News, Hem/OncsTweet-
I really enjoyed speaking with Dr. Henri Ford, Dean of @umiamimedicine on his podcast about prostate cancer and our team's ongoing work @PCF_Science https://t.co/lwhf4JlhI2
-
-
Mashup Score: 9How to Find the Right Oncologist for You - 5 month(s) ago
After a cancer diagnosis, it’s one of the most important decisions you’ll make.
Source: www.nytimes.comCategories: General Medicine News, Hem/OncsTweet-
How to Find the Right Oncologist for You https://t.co/JsI5LJyrap
-
-
Mashup Score: 44Adrenal-Permissive HSD3B1 Genotype and Prostate Cancer Mortality - 5 month(s) ago
Prostate cancer progression is dependent on androgen receptor signaling, which is activated by the circulating gonadal androgen testosterone and its more potent metabolite, 5α-dihydrotestosterone (DHT), generated from testosterone in the prostate. Androgen deprivation therapy (ADT) leading to the…
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet-
1/3 Congrats @DrRanaMcKay & MVP on @JAMANetworkOpen story showing HSD3B1⬆️prostate ca mortality in 5200 men! MVP suggests HSD3B1 is most common inherited driver of prostate ca mortality. Our commentary @SchifferLina explains our long obsession w/HSD3B1! https://t.co/BZxxpqnxmb
-
Poster titles, first authors and institutions are out for next week’s Miami Symposium on Human Metabolism! Check them out here! Still a few seats left for those interested in registering for the meeting at the Royal Palm in South Beach! https://t.co/3DqO4Pe6cw